HRS 2015: Boston Scientific touts cost-saving data for Watchman

Boston Scientific presents data at the Heart Rhythm Society's annual meeting showing that its Watchman anti-stroke device lowers costs compared with the blood thinner warfarin and aspirin.

Boston Scientific, HRS 2015

News Well, Clinical Trials, Cardiac Implants, Stroke

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1A2gQUt